COPD Asthma
15
0
0
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Cytisine vs Nicotine Replacement Therapy
Pulmonary Specialist-Health Coach Consult Model Study
ORCHARD- Optimising Home Assessment of Rural Patients
Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
Evaluation of the Right Use of Inhaled Therapeutics
Home Spirometry in Primary Care: an Implementation Study
Development and Evaluation of Clinical Pharmacy Services in Respiratory Diseases
The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD
Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma
The Role of Gas Flow in Transnasal Pulmonary Aerosol Delivery: A Double-blinded, Randomized Controlled Trial
The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
Accuracy of Spircare Device as Compared to the Conventional Plethysmograph
Identifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic Implications
Evaluation of Inhalation Technique in Patients With COPD, Asthma or ACOS Using a Dry Powder Device (DPI)